Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

Derrick Morgan Jr. built a $500,000-a-year trademark law firm that lets him work remotely, travel the world and live ...

Chinese smartphone company Xiaomi priced its luxury YU7 SUV within expectations — but undercut Tesla’s Model Y.

Merck’s stock just broke above its 50-day simple moving average, signaling a potential short-term bullish trend despite ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

In China, RSV accounted for an estimated 3.5 million ALRTI cases and up to 950,000 hospitalizations in 2019—nearly one-quarter of the global burden. While most cases are mild, RSV can cause severe ...

RSV is the focus of a new national pediatric guideline in China aimed at standardizing diagnosis, treatment, and prevention strategies for respiratory tract infections in children ...